This bill requires the Committee on Foreign Investment in the United States (CFIUS) to review and mandate disclosure for certain Chinese government-backed investments in U.S. real estate used for manufacturing facilities. It targets transactions where a Chinese entity (or acting for the Chinese government) purchases or leases land to build a factory and could result in Chinese government control through ownership, board appointments, or ties to the Chinese Communist Party. The bill amends CFIUS rules to include these as "covered transactions" and mandates a declaration for such investments. This applies to investments potentially linked to China's Belt and Road Initiative, as reflected in the bill's title.
The Child Tax Credit for Pregnant Moms Act of 2023 allows parents to claim the child tax credit for unborn children in two specific scenarios: for the tax year immediately before a child's birth (if a Social Security number is provided on the return), or for the year of a miscarriage or stillbirth (if a government-issued certificate is submitted). It requires a new certificate of miscarriage or stillbirth, issued by the National Center for Health Statistics, which must include a health care provider's certification (excluding abortion centers) and a parent's sworn statement. The credit applies to the biological mother or her husband on a joint return and covers children born alive, stillborn, or miscarried after the bill's enactment. This change makes the credit accessible earlier in pregnancy and for pregnancy loss, without altering the standard credit amount for children born alive.
This bill adds multi-cancer early detection screening tests to Medicare Part B coverage, directly affecting Medicare beneficiaries. It creates a new coverage category for FDA-approved blood tests (like those analyzing cell-free DNA) that screen for multiple cancer types simultaneously, as defined in the bill. Medicare would cover these tests once every 12 months, and the bill clarifies that this change does not impact existing coverage for standard cancer screenings like mammograms or colonoscopies. The policy change ensures beneficiaries can access these new screening options without unnecessary delays after FDA approval.
House Resolution 527 (HRES 527), introduced on June 20, 2023, is a symbolic resolution condemning the rise in antisemitic violence and harassment targeting Jewish Americans. It directly addresses Jewish Americans affected by recorded increases in antisemitic incidents, including attacks on synagogues and hate speech. The resolution calls on all members of Congress to denounce antisemitism, commit to combating it, and advance accurate Holocaust education while countering Holocaust denial. As a non-binding resolution, it expresses congressional solidarity but does not create new laws or funding.
HJRES 69 is a resolution seeking to disapprove an Environmental Protection Agency (EPA) rule published on June 5, 2023, which established a "Federal Good Neighbor Plan" for the 2015 ozone air quality standards. The rule aimed to address ozone pollution crossing state lines, particularly affecting southeastern states and industries subject to the 2015 ozone standards. This resolution would block the rule from taking effect by invoking the Congressional Review Act, preventing it from being enforced. If enacted, it would directly stop the EPA from implementing this specific plan, impacting states and businesses that would have had to comply with the rule.
This bill updates federal grant programs to include all FDA-approved opioid overdose reversal agents (like naloxone), not just specific products. It requires the Health and Human Services Secretary to revise existing grant program materials by December 2023 to ensure references cover any approved agent. The change directly affects states and tribes receiving State Opioid Response Grants and Tribal Opioid Response Grants under the 21st Century Cures Act, as well as regional/national prevention grants under the Public Health Service Act. This allows grantees greater flexibility to use the most effective, currently available reversal agents in their opioid response efforts.
S 2005, the Mandatory Materiality Requirement Act of 2023, would require the Securities and Exchange Commission (SEC) to specify in new disclosure rules that public companies must only disclose information the company determines is important for investment decisions. The bill amends the Securities Acts of 1933 and 1934 to mandate that the SEC explicitly state in rulemaking that disclosure obligations apply only when information is material - meaning a reasonable investor would consider its omission significant to their decision. This applies to all SEC rulemaking on disclosure requirements for public companies, though it excludes rules that would reduce disclosure burdens. The bill does not change current disclosure standards but alters how future SEC rules must be structured.
This bill requires group health plans (like employer-sponsored insurance) to provide equal cost-sharing (such as copays and deductibles) for oral anticancer medications as for intravenous or injected versions, provided a doctor deems the oral drug medically necessary. It prohibits plans from changing coverage to increase out-of-pocket costs for oral drugs or impose stricter limits on them compared to IV drugs. The requirement applies to FDA-approved anticancer drugs used to treat cancer, with plans still allowed to use prior authorization. The law takes effect for 2024 plan years.
The CONNECT for Health Act of 2023 expands Medicare telehealth coverage by removing geographic restrictions, allowing services to be provided from home and other locations, and expanding who can offer telehealth services. The bill repeals the six-month in-person visit requirement for telemental health and allows telehealth use in hospice care recertification. It also includes program integrity measures to address inappropriate billing patterns and requires posting of telehealth service data to improve transparency. This legislation directly affects Medicare beneficiaries, healthcare providers, and telehealth technology vendors by making telehealth more accessible, particularly for rural and underserved populations, those with mobility challenges, and individuals in areas with healthcare workforce shortages.
The Noninsured Crop Disaster Assistance Program Enhancement Act of 2023 removes a longstanding exclusion that previously prevented crops and grasses used for grazing from receiving disaster aid. This change allows farmers who grow forage crops and grasses for livestock grazing to access program benefits if their crops are damaged by natural disasters like droughts or floods. The bill amends two specific sections of the existing law to eliminate the exclusion, making grazing crops eligible under the program. Regulations implementing this change must be issued by the Secretary of Agriculture within 90 days of the bill's enactment.
This bill prohibits state and local governments from imposing additional production standards on agricultural products grown in another state but sold in interstate commerce, unless those standards already apply under federal law or the state where production occurs. It directly affects farmers, distributors, and businesses operating across state lines by preventing states from creating new barriers to interstate agricultural trade. Key provisions include creating a federal legal right for affected parties to challenge such state regulations in court, with automatic preliminary injunctions to halt enforcement pending resolution. The law also sets a 10-year limit for filing lawsuits and specifies where cases can be heard.
This proposed constitutional amendment would authorize Congress to pass laws prohibiting physical desecration of the U.S. flag, such as burning, mutilating, or trampling it. If ratified by three-fourths of state legislatures within seven years of congressional submission, it would enable federal laws to criminalize such acts. The amendment requires states to approve it within a seven-year window after the Senate introduces the resolution.
